14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.58 $5.85 Friday, 3rd May 2024 CTMX stock ended at $4.43. This is 1.56% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 14.22% from a day low at $4.43 to a day high of $5.06.
90 days $1.38 $5.85
52 weeks $1.04 $5.85

Historical CytomX Therapeutics prices

Date Open High Low Close Volume
Jan 19, 2022 $3.87 $4.16 $3.83 $4.08 1 055 100
Jan 18, 2022 $4.18 $4.28 $3.83 $3.83 1 170 200
Jan 14, 2022 $3.70 $3.95 $3.67 $3.95 721 000
Jan 13, 2022 $3.77 $3.87 $3.68 $3.74 716 700
Jan 12, 2022 $4.02 $4.02 $3.75 $3.76 668 300
Jan 11, 2022 $3.92 $4.08 $3.86 $3.98 748 000
Jan 10, 2022 $3.86 $3.93 $3.73 $3.93 696 800
Jan 07, 2022 $4.10 $4.15 $3.87 $3.89 667 300
Jan 06, 2022 $3.97 $4.16 $3.90 $4.12 895 700
Jan 05, 2022 $4.25 $4.31 $3.99 $3.99 784 016
Jan 04, 2022 $4.59 $4.64 $4.17 $4.19 1 063 532
Jan 03, 2022 $4.45 $4.53 $4.27 $4.49 745 867
Dec 31, 2021 $4.24 $4.45 $4.22 $4.33 642 763
Dec 30, 2021 $4.47 $4.57 $4.38 $4.40 849 193
Dec 29, 2021 $4.31 $4.53 $4.27 $4.47 956 956
Dec 28, 2021 $4.25 $4.38 $4.23 $4.34 959 963
Dec 27, 2021 $4.16 $4.33 $4.08 $4.23 1 380 287
Dec 23, 2021 $4.08 $4.31 $4.08 $4.22 2 034 228
Dec 22, 2021 $3.81 $4.14 $3.74 $4.05 3 973 353
Dec 21, 2021 $5.05 $5.06 $3.68 $3.87 15 422 051
Dec 20, 2021 $6.33 $6.51 $5.89 $6.45 1 189 599
Dec 17, 2021 $6.20 $6.75 $6.02 $6.39 4 797 266
Dec 16, 2021 $6.70 $6.75 $6.30 $6.32 854 405
Dec 15, 2021 $6.10 $6.71 $6.04 $6.68 1 914 224
Dec 14, 2021 $6.35 $6.35 $5.84 $6.05 1 123 338
Click to get the best stock tips daily for free!

About CytomX Therapeutics

CytomX Therapeutics CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical trials for the treatment of breast cancer; CX-2029 that is in Phase II clinical trials for the treatme... CTMX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT